We are live on ! Find out more
BRWA

B. Riley Wealth Advisors Portfolio holdings

AUM $1.87B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+8.24%
1 Year Est. Return
+37.01%
3 Year Est. Return
+105.27%
5 Year Est. Return
+122.55%
10 Year Est. Return
+465.52%
AUM
$3.7B
AUM Growth
-$16.7M
Cap. Flow
+$318M
Cap. Flow %
8.6%
Top 10 Hldgs %
20.23%
Holding
1,535
New
149
Increased
864
Reduced
388
Closed
90

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.59%
2 Technology 14.45%
3 Healthcare 6.56%
4 Consumer Discretionary 5.85%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZDGE icon
1351
Zedge
ZDGE
$40.1M
$110K ﹤0.01%
50,166
+8,625
+21% +$27.2K
BRSP
1352
BrightSpire Capital
BRSP
$525M
$109K ﹤0.01%
16,940
DNP icon
1353
DNP Select Income Fund
DNP
$3.82B
$108K ﹤0.01%
+11,269
New +$99.6K
VIV icon
1354
Telefônica Brasil
VIV
$19.1B
$106K ﹤0.01%
+12,199
New +$128K
CLM icon
1355
Cornerstone Strategic Value Fund
CLM
$1.97B
$106K ﹤0.01%
13,385
-875
-6% -$6.24K
CIM
1356
Chimera Investment
CIM
$910M
$105K ﹤0.01%
6,208
+455
+8% +$6.34K
MVT
1357
DELISTED
BlackRock MuniVest Fund II
MVT
$105K ﹤0.01%
+11,229
New +$121K
VKQ icon
1358
Invesco Municipal Trust
VKQ
$507M
$105K ﹤0.01%
+12,550
New +$120K
SELF
1359
Global Self Storage
SELF
$57.4M
$99.7K ﹤0.01%
20,520
CMPX icon
1360
Compass Therapeutics
CMPX
$342M
$98.5K ﹤0.01%
50,000
ACHR icon
1361
Archer Aviation
ACHR
$4.05B
$94.4K ﹤0.01%
18,655
-1,900
-9% -$9.54K
ABEV icon
1362
Ambev
ABEV
$45.3B
$94.3K ﹤0.01%
36,566
+3,234
+10% +$8.42K
TVRD
1363
Tvardi Therapeutics
TVRD
$21.7M
$93.5K ﹤0.01%
1,546
-167
-10% -$4.33K
LPTH icon
1364
Lightpath Technologies
LPTH
$693M
$93.4K ﹤0.01%
64,395
-47,429
-42% -$68.1K
NHS
1365
Neuberger High Yield Strategies Fund Inc
NHS
$237M
$92.9K ﹤0.01%
12,337
-3,100
-20% -$24.9K
BCRX icon
1366
BioCryst Pharmaceuticals
BCRX
$2.22B
$92K ﹤0.01%
13,000
IGR
1367
CBRE Global Real Estate Income Fund
IGR
$625M
$90.8K ﹤0.01%
6,729
+1,514
+29% +$23.7K
IHD
1368
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$133M
$89.7K ﹤0.01%
18,191
ATNM icon
1369
Actinium Pharmaceuticals
ATNM
$38.4M
$86.1K ﹤0.01%
14,550
AWP
1370
abrdn Global Premier Properties Fund
AWP
$335M
$85K ﹤0.01%
7,785
CKPT
1371
DELISTED
Checkpoint Therapeutics
CKPT
$83.6K ﹤0.01%
49,150
-114,200
-70% -$228K
LEO
1372
BNY Mellon Strategic Municipals
LEO
$361M
$82.4K ﹤0.01%
15,400
LOAN
1373
Manhattan Bridge Capital
LOAN
$45M
$82.2K ﹤0.01%
17,133
+6,923
+68% +$33.3K
GPGI
1374
GPGI Inc
GPGI
$3.47B
$81.1K ﹤0.01%
+15,146
New +$68.3K
PSEC icon
1375
Prospect Capital
PSEC
$1.14B
$80.1K ﹤0.01%
13,116
-150
-1% -$863

Similar funds

B. Riley Wealth Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, B. Riley Wealth Advisors held 1,535 positions worth $3.7B, down 0.45% from $3.71B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

B. Riley Wealth Advisors deployed $318M of net new capital in Q1 2024, opening 149 new positions and adding to 864 existing holdings. Its largest new stake was Invesco BuyBack Achievers ETF: 71,926 shares worth $6.47M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 45% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $11.3M trimmed.

  • B. Riley Wealth Advisors's largest Q1 2024 buy was Invesco BuyBack Achievers ETF: 71,926 shares worth $6.47M.
  • B. Riley Wealth Advisors added most to Vanguard Morningstar Growth ETF in Q1 2024, an estimated $25.7M increase.
  • B. Riley Wealth Advisors's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $11.3M.
  • B. Riley Wealth Advisors fully exited US Treasury 10 Year Note ETF in Q1 2024, selling an estimated $6.72M.
  • B. Riley Wealth Advisors's ten largest holdings make up 20% of its $3.7B portfolio in Q1 2024.
  • B. Riley Wealth Advisors opened 149 new positions and closed 90 in Q1 2024.
  • B. Riley Wealth Advisors's portfolio value fell 0.45% quarter-over-quarter to $3.7B.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2024, filed 16 May 2024.